Physician profile
Evan Glazer
NPI 1790999308
$22,310.73
in general payments reported to CMS, 2019-2025
22 companies · $1,939 in 2025
The $1,939 reported for 2025 was more than what 81% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2021: $129 · 2022: $845 · 2023: $1,581 · 2024: $6,026 · 2025: $1,939.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,539 · Education: $2,225 · Food and Beverage: $2,177 · Consulting Fee: $596 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,538.81 |
| Education | $2,225.31 |
| Food and Beverage | $2,177.23 |
| Consulting Fee | $595.83 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien Lp | $11,356.45 | 2019 | |
| Intuitive Surgical, INC. | $8,418.10 | 2019-2025 | Da Vinci Surgical System |
| Becton, Dickinson and Company | $595.83 | 2024 | |
| Medtronic, INC. | $583.09 | 2022-2023 | Signia |
| Delcath Systems | $291.16 | 2024-2025 | Hepzato Kit |
| Myriad Genetic Laboratories, INC. | $222.86 | 2021-2022 | |
| Biocompatibles, INC. | $142.90 | 2019 | |
| Genentech USA, INC. | $125.45 | 2019 | |
| Tempus Ai, INC | $125.00 | 2025 | Xt Cdx |
| Abbvie INC. | $116.77 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $86.40 | 2025 | |
| Integra Lifesciences Corporation | $48.66 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Histosonics, INC. | $43.85 | 2024 | |
| Z-Medica, LLC | $26.62 | 2019 | |
| Intera Oncology, INC | $22.35 | 2025 | Intera |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $21.85 | 2025 | Erleada, Akeega, Balversa |
| Amgen INC. | $15.97 | 2022 | |
| Boston Scientific Corporation | $14.36 | 2023 | Spyglass |
| Dilon Technologies, INC. | $14.05 | 2025 | Hemoblast Bellows |
| Ambu INC. | $13.45 | 2023 | |
| Kci USA, INC. | $13.42 | 2021 | |
| Healthmyne, INC. | $12.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evan Glazer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.